From Mental Health Issues to Cancer Care: AI Startups Reimagine Healthcare Access with Smart Diagnostics, Digital Tools, Tele-Doctors
At the AI Impact Summit in New Delhi, several startups unveiled AI‑driven solutions aimed at widening healthcare access. Clinics on Cloud introduced “Health ATMs” that combine on‑site screenings for 60+ conditions with tele‑doctor consults, claiming 90‑95% laboratory‑grade accuracy. Other launches included Tranquil AI’s personalized mental‑health platform for students, OncoVault’s AI‑powered cancer‑report aggregator, and Bhargati’s biomechanics coaching tool for remote athletes. Together, these products illustrate how AI is being leveraged to deliver diagnostics, chronic‑care management, and performance coaching to underserved populations.
State Bill to Standardize Nursing Home Admission Contracts, Limit Role of ‘Assistors’
New Jersey lawmakers introduced a bill requiring the Department of Health to create uniform admission contracts for nursing homes and assisted‑living facilities and to restrict Medicaid "assistors" from providing legal or financial guidance. The legislation also mandates clear notification of...
6 Lessons Shaping Health System Strategic Leaders’ Operational Approach for 2026
Health system leaders are reshaping 2026 operations amid technology, regulation, and labor pressures. Executives from Cedars‑Sinai to Novant Health stress frontline immersion, cost‑control focus, system‑design that simplifies right actions, and building trust through candid dialogue. Prioritizing a narrow set of...
TyG-BMI Can Help Predict In-Hospital Mortality in HFmrEF With Hypertension
A recent study published in Lipids in Health and Disease shows that the triglyceride‑glucose‑body‑mass‑index (TyG‑BMI) markedly improves prediction of in‑hospital mortality among hypertensive patients with heart failure with mildly reduced ejection fraction (HFmrEF). In a cohort of 2,550 admissions, each...
Learning From FDA’s Moderna U-Turn
The FDA abruptly reversed its decision to approve Moderna’s mRNA‑based flu vaccine after the White House intervened, sparking intense discussion in biotech boardrooms. The reversal was driven by political considerations rather than new scientific data, underscoring the agency’s vulnerability to...
Navigating the Expanding MS Treatment Landscape: Kavita Nair, PhD
The multiple sclerosis (MS) treatment landscape has exploded from four to 23 disease‑modifying therapies, giving clinicians a broad menu of oral, injectable, infusion, generic, and biosimilar options. Selecting a therapy now hinges on balancing efficacy and safety with real‑world factors...
Croom Medical Breaks Ground on R&D Site in Ireland
Croom Medical has broken ground on ACOT, a 38,000‑square‑foot Advanced Centre of Orthopaedic Technologies in Croom, County Limerick. The project represents the company’s largest capital outlay in its 42‑year history and will serve as a combined R&D and industrialisation hub....
How to Avoid a Fall by Balancing Cost and Performance in Drug Discovery
Balancing cost and performance in drug discovery requires a hybrid engineering‑led approach that combines on‑premise HPC with scalable cloud resources. Uncontrolled cloud scaling can drive unpredictable expenses, while pure on‑premise systems demand high upfront capital and maintenance. By implementing disciplined...
Elevance Health's Value-Based Care Models Deliver Measurable Quality Gains: Kristie Spencer
Elevance Health reported that 60.5% of its medical spend now flows through value‑based care contracts, with shared‑risk arrangements climbing to 37%—a 4‑point rise from the previous year. The company’s 2024 Advancing Health Together report shows that 76% of its value‑based...
Wet, Dry AMD Require Different Methods of Treatment, Including Anti-VEGF: Julie Rosenthal, MD, MS
Age‑related macular degeneration (AMD) affects roughly 19.8 million Americans and remains a leading cause of blindness. The disease is split into dry and wet forms, each requiring distinct therapeutic approaches. Wet AMD is managed with intravitreal anti‑VEGF injections, with newer agents...
CDC Enterprise Architect to Detail Digital Transformation at HIMSS26
At HIMSS26, CDC Acting Chief Enterprise Architect Ryan M. Harrison will unveil the agency’s Technical Reference Architecture (TRA), a unified framework that codifies IT standards across CDC. The presentation targets both IT leaders and developers, illustrating how the TRA integrates...
Altesa BioSciences Raises $75M Series B
Altesa BioSciences announced an oversubscribed $75 million Series B round, led by Forbion with participation from Sanofi and existing backers Medicxi, Pitango, and Atlantic Partners. The financing will support the development of its lead candidate, vapendavir, targeting viral-driven exacerbations in COPD and...
5-Day Preoperative Radiotherapy in High-Risk STS Shows Manageable Toxicity
A phase‑2 single‑center trial evaluated a five‑day pre‑operative radiotherapy schedule in 110 patients with high‑risk soft‑tissue sarcoma. At two‑year follow‑up, grade ≥ 2 radiation‑related toxicities were observed in 14 of 74 evaluable patients, with lower rates in the extension cohort. Major wound...
At an Inflection Point in HIV Science: Nicolas Chomont, PhD, Looks Ahead to CROI 2026
Nicolas Chomont, chair of CROI 2026’s scientific program, previewed the conference’s focus on emerging HIV research, including treatment, cure, and vaccine advances. The meeting will showcase extensive data on long‑acting antiretroviral therapies and address funding constraints affecting global HIV initiatives....
Health Equity & Access Weekly Roundup: February 20, 2026
The Guttmacher Institute reports a modest 2% drop in abortion clinics across non‑ban states, yet high churn—51 closures and 39 openings—creates instability, especially in Florida where a six‑week ban accelerated losses despite telehealth growth. New sickle‑cell disease therapies, including gene‑editing...
How Hospitals and Area Agencies on Aging Are Collaborating to Advance Social Connection
Hospitals and Area Agencies on Aging (AAAs) are launching joint programs to combat social isolation among older adults, a risk heightened by the fact that one‑fifth of Americans 50+ live alone. The collaborations leverage community health workers, technology platforms, and...
GoFundMe CEO on Why Crowdfunding Sparks Generosity and Judgment
GoFundMe’s CEO Tim Cadogan says health‑related fundraising remains the platform’s top category, with campaigns like the late actor James Van Der Beek’s raising $2.7 million. The company allows anyone facing out‑of‑pocket medical costs to start a fundraiser without disclosing personal financial details. Cadogan and...
CDC Report Highlights Low Use of COVID-19 Antivirals Among People 65 and Older
The CDC’s February 19 MMWR report shows that only a minority of Americans aged 65 and older received FDA‑approved COVID‑19 antiviral prescriptions in recent months. From June 2023 through September 2025, antiviral use was 16‑23% during periods of low community transmission and rose...
Important Takeaways From Medtronic’s (MDT) Q3 2026 Earnings Report
Medtronic reported Q3 2026 adjusted earnings of $1.36 per share, beating expectations, while revenue climbed 8.7% to $9.0 billion, led by a 13.8% surge in its cardiovascular unit. Operating margin slipped to 16.2% from 19.9% as the company intensified R&D spending...
Ten63 Therapeutics Secures New Funding
Ten63 Therapeutics, an AI‑driven drug‑discovery firm spun out of Duke and TTIC, announced a strategic investment from Chugai Venture Fund and the Bill & Melinda Gates Foundation, bringing total capital to over $45 million. The company leverages its BEYOND generative‑chemistry platform...
FDA Approves Expanded Use of Gadolinium-Based Imaging Agent From Guerbet
The U.S. FDA has approved an expanded label for Guerbet’s gadolinium‑based contrast agent Elucirem (gadopiclenol), allowing its use in infants and children under two years, including term neonates. The agent delivers high‑relaxivity imaging with less than half the gadolinium dose...
Hormone-Regulated Immune Cells Implicated in Longer Lasting Pain in Women
Researchers at Michigan State University discovered that hormone‑regulated monocytes producing interleukin‑10 (IL‑10) drive faster pain resolution in males. In mouse models, testosterone‑dependent IL‑10+ monocytes cleared inflammatory pain more quickly, while females exhibited fewer of these cells and prolonged pain. Human...
Can Smartphones Replace $25,000 Eye-Testing Gear? This Startup Says Yes
Danish startup OptikosPrime claims its Argus app can generate a full eyeglass prescription using only a smartphone camera. In prototype tests the app achieved a mean absolute error of 0.51 diopters, approaching the 0.25‑diopter threshold of professional autorefractors. The solution...
Ceftriaxone - Injection Products
The latest ceftriaxone injection labeling clarifies susceptibility breakpoints for anaerobic organisms, defining a minimum inhibitory concentration of ≤1 µg/mL as susceptible. For Haemophilus influenzae and H. parainfluenzae, the interpretive criteria assume a 2 g IV dose every 24 hours in patients with normal...
HIMSS26 to Host Native American & Indigenous Health Symposium
The HIMSS26 conference will host the fourth Native American & Indigenous Health Symposium, bringing together tribal and Indigenous health leaders from the U.S., Canada, Australia and Alaska. Since its 2022 launch, the HIMSS Indigenous Community has expanded its network and...
Kansas City Launches Integrated Theranostics Platform Partnership
A public‑private partnership between the University of Kansas Health System, KU Medical Center, Children’s Mercy and Bold Advanced Medical Future (BAMF) Health is launching an integrated theranostics platform in Kansas City. The center will combine molecular imaging, radiopharmaceutical production, clinical...
Alliance of Companies Will Help Accelerate $50 Billion in Rural Health Programs
Science Applications International Corp. (SAIC) has launched the Alliance for Advancing Rural Healthcare (AARH), uniting seven partners—including Arcadia, Castlight Health, Covista, Mission Mobile Medical, Telemedicine.com, TruBridge and Walgreens—to execute the $50 billion Rural Health Transformation program. The alliance will bolster the...
AI Impact Summit: Meet ‘LuSI’, the ‘Made in India’ AI-Integrated Robotic Baby Revolutionising Medical Training
At the India AI Impact Summit 2026, Maverick Simulation Solutions unveiled LuSI, a 2.5 kg AI‑integrated robotic newborn that replicates real‑time respiratory conditions for high‑fidelity medical training, already adopted by AIIMS, AFMC and PGI. The same event highlighted PhonePe's launch of...
Athenahealth Launches Agentic Patient Comms Tools Across Provider Network
athenahealth unveiled the next generation of its AI‑native patient engagement suite within athenaOne, adding text and voice virtual assistants that let patients schedule appointments and ask routine questions 24/7. The texting feature is in alpha and will roll out broadly...
In the Clinic for Feb. 20, 2026
The February 20 2026 "In the Clinic" roundup aggregates a broad set of industry snapshots, special reports, and infographics covering biopharma, medical technology, and emerging research areas. It links to data on mRNA vaccine research, China’s GLP‑1 market, pulsed‑field ablation for atrial...
Money Raised by Biopharma
Recent biopharma research highlights IL‑22 and TL1A as a powerful biomarker pair for diagnosing hidradenitis suppurativa (HS), while TL1A overexpression is confirmed in patient lesions. Parallel studies reveal that inhibiting the NLRP3 inflammasome may mitigate vascular cognitive impairment and stroke‑related...
Single Yes-or-No Question May Screen for Low Vision
A study published in Investigative Ophthalmology & Visual Science shows that a single yes‑or‑no question can reliably screen for low vision and legal blindness, achieving area‑under‑the‑curve (AUC) values of 0.81 and 0.77 respectively. Researchers tested 385 adults across four U.S....
Encompass Health, Enhabit Secure $43.1M Judgement in VitalCaring Case
Encompass Health and Enhabit secured a $43.1 million award covering attorneys’ fees and mitigation damages after a Delaware federal judge ruled that 43% of VitalCaring’s profits and any future sale proceeds must be placed in a trust for the two companies....
Generic Drugs Forum (GDF) 2026 - 04/22/2026
On April 22‑23, 2026, the FDA’s Center for Drug Evaluation and Research hosted the annual Generic Drugs Forum at its White Oak Campus, with a virtual option via Adobe Connect. The two‑day event gathered generic drug developers, consultants, and regulatory...
AI-Based Platform Supports Community Health Workers in Street Medicine Program
Akido Labs has deployed an AI‑native platform that equips community health workers with real‑time data collection, documentation, and patient‑engagement tools for street‑medicine teams. The model aligns with California’s CalAIM whole‑person care framework and shifts the heavy reporting burden away from...
Proven Methodologies For Ensuring Seamless CRM Migrations In Highly Regulated Environments
CRM migrations in healthcare and life sciences are accelerating amid tighter regulations such as HIPAA, GDPR, and FDA 21 CFR Part 11. Avenga’s Roman Bevz outlines a compliance‑by‑design methodology that starts with mapping data to regulatory obligations and proceeds through risk analysis,...
‘Magical Outcomes’: The Case for Launching PACE
Programs for All‑Inclusive Care of the Elderly (PACE) remain among the most complex value‑based models to launch, demanding multi‑million dollar capital, state contracts, and intricate regulatory compliance. SCAN Group’s myPlace Health, now fully owned after buying out Commonwealth Care Alliance,...
Macrophage Phenotype–Dependent Protein Corona Formation Governs Ligand Accessibility and Immune Clearance of Biomimetic Nanoparticles
Researchers coated magnetic silica nanoparticles with membranes from naïve (M0), classically activated (M1) and alternatively activated (M2) macrophages to study phenotype‑dependent protein corona formation. Proteomic analysis showed M0‑derived membranes adsorbed the fewest opsonins (C3, IgG, IgM) and triggered the lowest...
Senseonics Launches Automated Insulin Dosing System with 1-Year CGM
Senseonics and Sequel Med Tech have launched an automated insulin‑delivery system that pairs the year‑long Eversense 365 implantable CGM with Sequel’s twiist pump. The integration, delayed to Q4 2025, marks the first AID solution using a one‑year sensor, contrasting with competitors’ 15‑day...
Continuing Our Efforts to Address Violence
The American Hospital Association (AHA) is intensifying its fight against violence in health‑care settings by releasing a joint guide with the FBI on behavioral threat assessment and management (BTAM). The guide provides evidence‑based strategies, training recommendations, and case studies from...
AI in Cardiovascular Imaging and Interventions: Boon or Bane?
At the 2026 EAPCI Summit, experts highlighted AI’s expanding role in cardiovascular interventions, from mortality risk modeling to intravascular imaging analysis. A University of Galway study identified gamma‑glutamyl transferase as a strong 10‑year mortality predictor in the SYNTAX cohort, validated...
A Quercetin Nanocarrier‐Loaded Dual Network Injectable Hydrogel for Mesenchymal Stem Cells (MSCs) Delivery Targeting Osteoarthritis
Researchers have created an injectable dual‑network hydrogel composed of gelatin methacrylate and κ‑carrageenan that embeds quercetin‑loaded PLGA nanoparticles for mesenchymal stem cell (MSC) delivery in osteoarthritis (OA). The antioxidant hydrogel scavenges reactive oxygen species, reprograms M1 macrophages to an anti‑inflammatory...
Advanced Approaches to Pediatric Fluid and Electrolyte Therapy: What Pharmacists Need to Know
The article outlines modern pediatric fluid and electrolyte therapy, emphasizing isotonic maintenance IV solutions to curb hyponatremia and detailing the Holliday‑Segar and BSA‑based calculation methods. It differentiates oral rehydration for mild‑to‑moderate dehydration from phased isotonic bolus and deficit‑plus‑maintenance IV regimens...
STAT+: Pharmalittle: We’re Reading About an FDA Official’s Speech, a Grail Cancer Blood Test, and Much More
FDA drug‑center head Tracy Beth Høeg used her first staff address to flag two priority areas: the safety of antidepressants taken during pregnancy and the use of monoclonal antibodies that protect infants from RSV. She also signaled a continued interest...
Ready to Grow Your Surgery Center Without Losing Your Sanity
Surgery centers are expanding rapidly, but growth brings regulatory, staffing, and technology challenges that can overwhelm internal teams. Without a structured plan, new service lines often trigger credentialing, supply chain, and workflow gaps, leading to delays and cost overruns. Ambulatory...
To Streamline Workflows, Listen to Clinicians
Chief Clinical Officer Dr. Michael Zappa of Cape Fear Valley Health, also a physician advisor at Juno Health, urges healthcare leaders to directly ask clinicians which administrative duties pull them away from patient care. He recommends mapping these tasks and...
FDA Starts Review of Regeneron's Drug for Rare Disease FOP
The FDA has placed Regeneron's anti‑activin A antibody garetosmab under priority review, with a decision expected by August. Phase 3 OPTIMA data showed a 94% reduction in new heterotopic ossification lesions at the lower dose and a 90% reduction at the higher...
Evolving Frontline Treatment Strategies in Diffuse Large B-Cell Lymphoma
Frontline treatment of diffuse large B‑cell lymphoma (DLBCL) is shifting from traditional R‑CHOP toward targeted and bispecific antibody‑based regimens. The POLARIX phase‑3 trial demonstrated that Pola‑R‑CHP improves progression‑free survival, particularly in activated‑B‑cell (ABC) disease and older patients. Early phase studies...
Nanozyme Aptasensor: A Breakthrough in S. Aureus Diagnostics
Researchers have unveiled a nanozyme‑aptamer colorimetric array that classifies Staphylococcus aureus strains with 100% accuracy, including methicillin‑resistant variants. The platform couples gold‑nanoparticle nanozymes with four strain‑specific aptamers, producing distinct color fingerprints that are decoded by hierarchical clustering and linear discriminant...
CHS Could Slow Pace of Divestitures as It Makes Progress Paying Debt
Community Health Systems (CHS) announced it will decelerate its aggressive divestiture program as it focuses on strengthening core markets. The for‑profit hospital chain has cut its debt leverage to 6.6× in 2025, down from 7.4× the year before, and boosted...